HOUSTON, April 29, 2004 - Omega Protein Corporation (NYSE symbol: OME), the world's largest manufacturer of heart-healthy fish oils containing long-chain Omega-3 fatty acids, today reported net income for the first quarter of 2004 of $646,000 (3 cents per share), compared with net income of $2.6 million, or 11 cents a share, for the first quarter of the previous year.
Revenues for the first quarter of 2004, which ended March 31, were $25.1 million, versus revenues of $25.1 million for the year-earlier quarter. Omega Protein had operating income of $1.2 million for the first quarter of 2004, compared with operating income of $4.2 million in the comparable quarter of the previous year. First quarter 2004 margins were reduced from the prior year's comparable quarter due to higher cost inventory being carried forward into 2004.
Omega Protein Corporation is the nation's largest manufacturer of heart-healthy fish oils containing Omega-3 fatty acids for human consumption, as well as specialty fish meals and fish oil used as value-added ingredients in aquaculture, swine and other livestock feeds. Omega Protein makes its products from menhaden, an Omega-3 rich fish that is not utilized as seafood, but which is abundantly available along the U.S. Gulf of Mexico and Atlantic Coasts.
Special Note Regarding Forward-Looking Statements: The statements contained in this press release that are not historical facts are forward-looking statements that involve a number of risks and uncertainties. The actual results of future events described in any of these forward-looking statements could differ materially from those stated in the forward-looking statements. Important factors that could cause actual results to be materially different from those forward -looking statements include, among others, (1) the Company's ability to meet its raw material requirements through its annual menhaden harvest, which is subject to fluctuations due to natural conditions over which the Company has no control, such as varying fish population, adverse weather conditions and disease; (2) the impact of worldwide supply and demand relationships on prices for the Company's products; and (3) fluctuations in the Company's quarterly operating results due to the seasonality of the Company's business and its deferral of inventory sales based on worldwide prices for competing products. These and other factors are described in further detail in Omega's filings with the Securities and Exchange Commission, including its 2003 Annual Report on Form 10K under the headings, "Management's Discussion and Analysis of Financial Condition and Results of Operations Significant Factors That May Affect Forward-Looking Statements" and "-Seasonality and Quarterly Results."
Contact: Investor Relations Department (713) 623-0060
or hq@omegaproteincorporation.com
OMEGA PROTEIN CORPORATION
Statement of Operations(unaudited)
|
Three Months Ended March 31, |
|
 |
|
2004 |
|
2003 |
|
| (in thousands, except per share amounts) |
|
| Revenues |
$25,056 |
|
$25,101 |
|
|
| Cost of Sales |
21,382 |
|
18,679 |
|
|
| Gross Profit |
3,674 |
|
6,422 |
|
|
| Selling, general, and administrative expense |
2,462 |
|
2,196 |
|
|
| Operating income |
1,212 |
|
4,226 |
|
|
| Interest Expense, net |
(187) |
|
(154) |
|
|
| Other Expense, net |
(56) |
|
21 |
|
|
| Income before income taxes |
969 |
|
4,093 |
|
|
| Provision for income taxes |
323 |
|
1,446 |
|
|
| Net income |
$646 |
|
$2,647 |
|
|
| Basic earnings per share |
$0.03 |
|
$0.11 |
|
|
| Average common shares outstanding |
24,405 |
|
23,983 |
|
|
| Diluted earnings per share |
$0.02 |
|
$0.10 |
|
|
| Average common shares and common share eqivalents outstanding |
26,343 |
|
25,433 |
|
|
OMEGA PROTEIN CORPORATION CONDENSED BALANCE SHEET (unaudited)
| ASSETS |
March 31, 2004 |
December 31, 2003 |
| (in thousands, except per share amounts) |
|
| Current assets |
$93,272 |
$97,445 |
|
| Property and equipment, net |
86,957 |
85,231 |
|
| Deferred tax assets, net |
107 |
405 |
|
| Other assets |
2,576 |
3,087 |
|
| Total assets |
182,912 |
186,168 |
|
| LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
| Current liabilities |
12,761 |
16,508 |
|
| Long-term debt |
17,196 |
17,605 |
|
| Other long-term liabilities |
7,012 |
6,838 |
|
| Stockholders' equity |
145,943 |
145,217 |
|
| Total liabilities and stockholders equity |
$182,912 |
$186,168 |
| BOOK VALUE PER SHARE OUTSTANDING |
$5.98 |
$5.95 |
|
